# ALPs Single ChambEr New Device Study

> **NCT07469579** · NA · NOT_YET_RECRUITING · sponsor: **Cairdac SA** · enrollment: 15 (estimated)

## Conditions studied

- Brady-tachy Syndrome
- Brady Arrythmia
- Bradycardia
- AV Block
- Atrial Fibrillation (Paroxysmal)

## Interventions

- **DEVICE:** Leadless ventricular pacemaker implantation

## Key facts

- **NCT ID:** NCT07469579
- **Lead sponsor:** Cairdac SA
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-03
- **Final completion:** 2028-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469579, "ALPs Single ChambEr New Device Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07469579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*